Lawrence Cameron William 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed May 10, 2012
Insider Transaction Report
Form 4
Lawrence Cameron William
Principal Financial Officer
Transactions
- Award
Stock Option (right to buy)
2012-05-08+3,000→ 3,000 totalExercise: $13.00Exp: 2022-05-08→ Common (3,000 underlying) - Award
Restricted Stock Units
2012-05-08+1,500→ 1,500 totalExp: 2016-01-31→ Common (1,500 underlying) - Award
Restricted Stock Units
2012-05-08+3,250→ 3,250 totalExp: 2014-04-30→ Common (3,250 underlying)
Footnotes (4)
- [F1]The options vest in monthly installments over 48 months commencing January 1, 2012.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's Common stock.
- [F3]The restricted stock units vest 25% annually on the later of: (i) each anniversary of January 1, 2012; and (ii) the first day thereafter during which the issuer's trading window is open.
- [F4]The restricted stock units vest 100% on the later of (i) achievement of both the successful enrollment and release of data from certain clinical trials, and (ii) the first trading day thereafter on which the issuer's trading window is open.